KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Debt (2016 - 2026)

Gilead Sciences filings provide 17 years of Total Debt readings, the most recent being $24.9 billion for Q4 2025.

  • On a quarterly basis, Total Debt fell 6.65% to $24.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $24.9 billion, a 6.65% decrease, with the full-year FY2025 number at $24.9 billion, down 6.65% from a year prior.
  • Total Debt hit $24.9 billion in Q4 2025 for Gilead Sciences, roughly flat from $24.9 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $30.2 billion in Q2 2021 to a low of $23.2 billion in Q3 2024.
  • Median Total Debt over the past 5 years was $25.2 billion (2022), compared with a mean of $25.8 billion.
  • The widest YoY moves for Total Debt: up 25.2% in 2021, down 14.99% in 2021.
  • Gilead Sciences' Total Debt stood at $26.7 billion in 2021, then fell by 5.49% to $25.2 billion in 2022, then dropped by 0.96% to $25.0 billion in 2023, then increased by 6.9% to $26.7 billion in 2024, then fell by 6.65% to $24.9 billion in 2025.
  • The last three reported values for Total Debt were $24.9 billion (Q4 2025), $24.9 billion (Q3 2025), and $24.9 billion (Q2 2025) per Business Quant data.